These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8169411)

  • 21. In vitro stimulation of peripheral blood mononuclear cells (PBMC) from HIV- and HIV+ chancroid patients by Haemophilus ducreyi antigens.
    Van Laer L; Vingerhoets J; Vanham G; Kestens L; Bwayo J; Otido J; Piot P; Roggen E
    Clin Exp Immunol; 1995 Nov; 102(2):243-50. PubMed ID: 7586673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid.
    Abeck D; Korting HC
    Acta Derm Venereol Suppl (Stockh); 1992; 174():1-20. PubMed ID: 1636361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemophilus ducreyi requires an intact flp gene cluster for virulence in humans.
    Spinola SM; Fortney KR; Katz BP; Latimer JL; Mock JR; Vakevainen M; Hansen EJ
    Infect Immun; 2003 Dec; 71(12):7178-82. PubMed ID: 14638812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience.
    Janowicz DM; Ofner S; Katz BP; Spinola SM
    J Infect Dis; 2009 Jun; 199(11):1671-9. PubMed ID: 19432549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers.
    Bauer ME; Townsend CA; Ronald AR; Spinola SM
    Microbes Infect; 2006 Aug; 8(9-10):2465-8. PubMed ID: 16872858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemophilus ducreyi infection causes basal keratinocyte cytotoxicity and elicits a unique cytokine induction pattern in an In vitro human skin model.
    Hobbs MM; Paul TR; Wyrick PB; Kawula TH
    Infect Immun; 1998 Jun; 66(6):2914-21. PubMed ID: 9596767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of humoral and cell-mediated inducible immunity to Haemophilus ducreyi in an animal model of chancroid.
    Desjardins M; Filion LG; Robertson S; Kobylinski L; Cameron DW
    Infect Immun; 1996 May; 64(5):1778-88. PubMed ID: 8613391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of human natural killer cell activation by Haemophilus ducreyi.
    Li W; Janowicz DM; Fortney KR; Katz BP; Spinola SM
    J Infect Dis; 2009 Aug; 200(4):590-8. PubMed ID: 19572804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of early interactions between Haemophilus ducreyi and host cells by using cocultured HaCaT keratinocytes and foreskin fibroblasts.
    Zaretzky FR; Kawula TH
    Infect Immun; 1999 Oct; 67(10):5352-60. PubMed ID: 10496916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of protective immunity to Haemophilus ducreyi in the temperature-dependent rabbit model of experimental chancroid.
    Hansen EJ; Lumbley SR; Richardson JA; Purcell BK; Stevens MK; Cope LD; Datte J; Radolf JD
    J Immunol; 1994 Jan; 152(1):184-92. PubMed ID: 8254191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.
    Janowicz DM; Fortney KR; Katz BP; Latimer JL; Deng K; Hansen EJ; Spinola SM
    Infect Immun; 2004 Aug; 72(8):4528-33. PubMed ID: 15271912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection.
    Bauer ME; Spinola SM
    Infect Immun; 2000 Apr; 68(4):2309-14. PubMed ID: 10722634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi.
    Alfa MJ; Olson N; Degagne P; Plummer F; Namaara W; Maclean I; Ronald AR
    J Infect Dis; 1993 May; 167(5):1206-10. PubMed ID: 8486955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of an Interaction Network between an Extracellular Bacterial Pathogen and the Human Host.
    Griesenauer B; Tran TM; Fortney KR; Janowicz DM; Johnson P; Gao H; Barnes S; Wilson LS; Liu Y; Spinola SM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemophilus ducreyi-induced interleukin-10 promotes a mixed M1 and M2 activation program in human macrophages.
    Li W; Katz BP; Spinola SM
    Infect Immun; 2012 Dec; 80(12):4426-34. PubMed ID: 23027536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DltA mutant of Haemophilus ducreyi Is partially attenuated in its ability to cause pustules in human volunteers.
    Janowicz D; Leduc I; Fortney KR; Katz BP; Elkins C; Spinola SM
    Infect Immun; 2006 Feb; 74(2):1394-7. PubMed ID: 16428791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.
    Ahmed HJ; Johansson C; Svensson LA; Ahlman K; Verdrengh M; Lagergård T
    Infect Immun; 2002 Feb; 70(2):899-908. PubMed ID: 11796625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of an isogenic hemolysin-deficient mutant in the human model of Haemophilus ducreyi infection.
    Palmer KL; Thornton AC; Fortney KR; Hood AF; Munson RS; Spinola SM
    J Infect Dis; 1998 Jul; 178(1):191-9. PubMed ID: 9652440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.
    Purcell BK; Richardson JA; Radolf JD; Hansen EJ
    J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.